Promotion of osteogenic differentiation by amnion/chorion membrane extracts

Yoon Young Go, Sung Eun Kim, Geum-Joon Cho, Sungwon Chae, Jae-Jun Song

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The amniotic membrane is a favorable biomaterial to apply in the field of tissue engineering because of its unique biological properties. Human amniotic membranes consist of 2-layered sheets containing numerous growth factors, cytokines and other bioactive substances. Methods: In this study, we explored the potential of amnion membrane extracts (AME) and amnion/chorion membrane extracts (A/CME) to promote osteogenic differentiation of osteoblast-like (MG-63) cells. MG-63 cells were cultured in osteogenic induction medium (OIM) with or without 100 μg/mL of AME or A/CME. To determine the early and late differentiation of osteogenesis, alkaline phosphatase (ALP) activity and calcium deposition were measured at 3, 7, 10 and 24 days. Expression of specific genes associated with osteogenic differentiation, including osteocalcin (OCN), osteopontin (OPN), runt domain-containing transcription factor (Runx2) and osterix (OSX) was also determined. Results: In vitro experiments demonstrated that A/CME increased ALP activity, osteogenic gene expression and mineralization under osteogenic-inducing conditions. Notably, we found that A/CME contained growth factors related to osteogenesis, including fibroblast growth factors and transforming growth factors, which potentially promoted osteogenic differentiation of MG-63 cells to a greater extent than AME. Conclusions: These results indicate that A/CME is capable of providing growth factors and other substrates for osteogenic differentiation, which significantly increased the efficacy of osteogenesis in MG-63 cells. Taken together, the results of this study suggest that human A/CME is a promising biomaterial with therapeutic potential in bone regeneration applications.

Original languageEnglish
Pages (from-to)e171-e180
JournalJournal of Applied Biomaterials and Functional Materials
Volume14
Issue number2
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Chorion
Amnion
Membranes
Osteogenesis
Intercellular Signaling Peptides and Proteins
Phosphatases
Biocompatible Materials
Biomaterials
Alkaline Phosphatase
Gene Expression
Osteopontin
Bone Regeneration
Transcription factors
Fibroblast Growth Factors
Osteocalcin
Osteoblasts
Transforming Growth Factors
Fibroblasts
Tissue Engineering
Tissue engineering

Keywords

  • Amnion membrane extracts
  • Amnion/chorion membrane extracts
  • Growth factors
  • Osteogenesis

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Cite this

Promotion of osteogenic differentiation by amnion/chorion membrane extracts. / Go, Yoon Young; Kim, Sung Eun; Cho, Geum-Joon; Chae, Sungwon; Song, Jae-Jun.

In: Journal of Applied Biomaterials and Functional Materials, Vol. 14, No. 2, 01.01.2016, p. e171-e180.

Research output: Contribution to journalArticle

@article{e5d312540e7e412db0946a498da0f690,
title = "Promotion of osteogenic differentiation by amnion/chorion membrane extracts",
abstract = "Background: The amniotic membrane is a favorable biomaterial to apply in the field of tissue engineering because of its unique biological properties. Human amniotic membranes consist of 2-layered sheets containing numerous growth factors, cytokines and other bioactive substances. Methods: In this study, we explored the potential of amnion membrane extracts (AME) and amnion/chorion membrane extracts (A/CME) to promote osteogenic differentiation of osteoblast-like (MG-63) cells. MG-63 cells were cultured in osteogenic induction medium (OIM) with or without 100 μg/mL of AME or A/CME. To determine the early and late differentiation of osteogenesis, alkaline phosphatase (ALP) activity and calcium deposition were measured at 3, 7, 10 and 24 days. Expression of specific genes associated with osteogenic differentiation, including osteocalcin (OCN), osteopontin (OPN), runt domain-containing transcription factor (Runx2) and osterix (OSX) was also determined. Results: In vitro experiments demonstrated that A/CME increased ALP activity, osteogenic gene expression and mineralization under osteogenic-inducing conditions. Notably, we found that A/CME contained growth factors related to osteogenesis, including fibroblast growth factors and transforming growth factors, which potentially promoted osteogenic differentiation of MG-63 cells to a greater extent than AME. Conclusions: These results indicate that A/CME is capable of providing growth factors and other substrates for osteogenic differentiation, which significantly increased the efficacy of osteogenesis in MG-63 cells. Taken together, the results of this study suggest that human A/CME is a promising biomaterial with therapeutic potential in bone regeneration applications.",
keywords = "Amnion membrane extracts, Amnion/chorion membrane extracts, Growth factors, Osteogenesis",
author = "Go, {Yoon Young} and Kim, {Sung Eun} and Geum-Joon Cho and Sungwon Chae and Jae-Jun Song",
year = "2016",
month = "1",
day = "1",
doi = "10.5301/jabfm.5000264",
language = "English",
volume = "14",
pages = "e171--e180",
journal = "Journal of Applied Biomaterials and Functional Materials",
issn = "1722-6899",
publisher = "Wichtig Publishing",
number = "2",

}

TY - JOUR

T1 - Promotion of osteogenic differentiation by amnion/chorion membrane extracts

AU - Go, Yoon Young

AU - Kim, Sung Eun

AU - Cho, Geum-Joon

AU - Chae, Sungwon

AU - Song, Jae-Jun

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background: The amniotic membrane is a favorable biomaterial to apply in the field of tissue engineering because of its unique biological properties. Human amniotic membranes consist of 2-layered sheets containing numerous growth factors, cytokines and other bioactive substances. Methods: In this study, we explored the potential of amnion membrane extracts (AME) and amnion/chorion membrane extracts (A/CME) to promote osteogenic differentiation of osteoblast-like (MG-63) cells. MG-63 cells were cultured in osteogenic induction medium (OIM) with or without 100 μg/mL of AME or A/CME. To determine the early and late differentiation of osteogenesis, alkaline phosphatase (ALP) activity and calcium deposition were measured at 3, 7, 10 and 24 days. Expression of specific genes associated with osteogenic differentiation, including osteocalcin (OCN), osteopontin (OPN), runt domain-containing transcription factor (Runx2) and osterix (OSX) was also determined. Results: In vitro experiments demonstrated that A/CME increased ALP activity, osteogenic gene expression and mineralization under osteogenic-inducing conditions. Notably, we found that A/CME contained growth factors related to osteogenesis, including fibroblast growth factors and transforming growth factors, which potentially promoted osteogenic differentiation of MG-63 cells to a greater extent than AME. Conclusions: These results indicate that A/CME is capable of providing growth factors and other substrates for osteogenic differentiation, which significantly increased the efficacy of osteogenesis in MG-63 cells. Taken together, the results of this study suggest that human A/CME is a promising biomaterial with therapeutic potential in bone regeneration applications.

AB - Background: The amniotic membrane is a favorable biomaterial to apply in the field of tissue engineering because of its unique biological properties. Human amniotic membranes consist of 2-layered sheets containing numerous growth factors, cytokines and other bioactive substances. Methods: In this study, we explored the potential of amnion membrane extracts (AME) and amnion/chorion membrane extracts (A/CME) to promote osteogenic differentiation of osteoblast-like (MG-63) cells. MG-63 cells were cultured in osteogenic induction medium (OIM) with or without 100 μg/mL of AME or A/CME. To determine the early and late differentiation of osteogenesis, alkaline phosphatase (ALP) activity and calcium deposition were measured at 3, 7, 10 and 24 days. Expression of specific genes associated with osteogenic differentiation, including osteocalcin (OCN), osteopontin (OPN), runt domain-containing transcription factor (Runx2) and osterix (OSX) was also determined. Results: In vitro experiments demonstrated that A/CME increased ALP activity, osteogenic gene expression and mineralization under osteogenic-inducing conditions. Notably, we found that A/CME contained growth factors related to osteogenesis, including fibroblast growth factors and transforming growth factors, which potentially promoted osteogenic differentiation of MG-63 cells to a greater extent than AME. Conclusions: These results indicate that A/CME is capable of providing growth factors and other substrates for osteogenic differentiation, which significantly increased the efficacy of osteogenesis in MG-63 cells. Taken together, the results of this study suggest that human A/CME is a promising biomaterial with therapeutic potential in bone regeneration applications.

KW - Amnion membrane extracts

KW - Amnion/chorion membrane extracts

KW - Growth factors

KW - Osteogenesis

UR - http://www.scopus.com/inward/record.url?scp=84969785276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969785276&partnerID=8YFLogxK

U2 - 10.5301/jabfm.5000264

DO - 10.5301/jabfm.5000264

M3 - Article

VL - 14

SP - e171-e180

JO - Journal of Applied Biomaterials and Functional Materials

JF - Journal of Applied Biomaterials and Functional Materials

SN - 1722-6899

IS - 2

ER -